RP-CNBI Faculty and Staff Present at the 2025 International Neuropsychological Society Meeting in New Orleans!
Faculty presentations included Dr. Annalise Rahman-Filipiak's "Return of Individual Neuropsychological & Biomarker Results Across the Alzheimer’s Disease Research Centers Network: Survey of Current Practices." Dr. Kyler Mulhauser presented the poster "Cognitive performance in older adults and recent cannabis use: Insights from a Propensity Score Matched analysis", Dr. Benjamin Hampstead presented the poster "Brain oxygenation patterns during immersive virtual reality in older adults", and Dr. Brett Schneider presented the poster "The Neural Correlates of Social Cognition in Behavioral Variant Frontotemporal Dementia: A Pilot Study." Graduate student Kylie Kadey presented the poster "Incremental Validity of Learning Slope Metrics in Predicting Brain Volume in Mild Cognitive Impairment and Dementia of the Alzheimer’s Type." Dr. Robert J. Ploutz-Snyder presented his CE workshop "Small-n-Friendly Experimental Designs & Statistical Approaches." Finally, Dr. Quentin Devignes presented an upcoming paper "Grey Matter Microstructural Integrity Stratified by Amyloid and Tau Status in Patients with Amnestic Mild Cognitive Impairment and Dementia of Alzheimer’s Type."
RP-CNBI research technician presentations included poster presentations by Mackenzie Kelley, Claire Pardo, Karen Hernandez-Reyes, and Mercedes Bishop (respectively, "Associations Between Visuospatial Cognition and Regional Amyloid and Tau in Mild Cognitive Impairment and Dementia of the Alzheimer Type", "Assessing the Role of Aβ and Tau in Modulating Simulated HD-tDCS Electric Fields in Cognitive Impairment", "Segregation of Attentional Networks is Associated with Visuospatial Performance in Older Adults with Cognitive Impairment", and "Activation Patterns in Healthy Older Adults During a Social Cognition Task Using Functional Near-Infrared Spectroscopy"). Andrew Hayes and Haley Kohl were both invited to speak about recent findings ("Metabolic and Structural Correlates in Primary Progressive Aphasia" and "An Educational Intervention to Support Informed Decision-Making Among Diverse Older Adults Considering Alzheimer’s Disease Biomarker Disclosure" respectively).
Posted 2/19/2025
The Importance
Each year, millions of Americans are left with cognitive, emotional, and behavioral deficits after sustaining a neurologic injury or developing a neurologic disease. These deficits can contribute to significant problems in everyday functioning, thereby reducing one’s independence and quality of life. Family members are often also affected by such change due to the increased caregiving needs, change in roles, and other related stressors. As many patients and their families know all too well, there are few treatment options for these cognitive and functional deficits. Although the fields of Cognitive Neuroscience and Neuropsychology have made remarkable advancements in the ability to evaluate “normal” brain functioning as well as the changes that occur after neurologic injury and disease, relatively little work has attempted to directly translate this knowledge to develop more effective treatments.
Our Mission
The primary mission of the Research Program on Cognition and Neuromodulation Based Interventions (RP-CNBI) is to identify and provide effective treatments for those with neurologic injury and disease. We strive to bridge the knowledge gap between academic-based research and real-world clinical practice in order to enhance functioning and quality of life in affected individuals. While we primarily focus on methods to assist older adults, including those with dementia, we remain committed to other causes of cognitive and functional impairment.
We integrate neuropsychological theory, modern neuroimaging methods, and a range of non-pharmacologic treatments in order to:
1) Understand changes in brain structure and function that underlie cognitive, emotional, and functional deficits
2) Establish research treatment “targets” that guide the selection of appropriate interventions
3) Evaluate research treatment-related changes in functioning
Potential research treatments include a range of non-pharmacologic methods such as cognitive rehabilitation and non-invasive brain stimulation (e.g., transcranial direct current stimulation – tDCS). Our ultimate goal is to establish empirical support for non-pharmacologic treatments and to disseminate the resulting methods for widespread clinical use.
Support our Mission:
Participate in Research
The Research Program on Cognition and Neuromodulation Based Interventions is currently conducting a range of federally- and privately-supported research studies. Click here to view our currently enrolling studies. If you, or a loved one, are interested in learning more about our studies as a potential participant, please fill out the link below:
Donate
Philanthropic support is especially important since each patient embodies a unique set of strengths, weaknesses, and needs that require an individualized approach that is not compatible with most forms of federal funding. We view each case as an opportunity to form a partnership and work to understand the needs and goal of each individual when developing the research interventions. We appreciate gifts of any amount, so please consider supporting our work.
Commitment to Diversity and Inclusion
Our program is committed to providing a welcoming environment which does not discriminate on the basis of race, ethnicity, color, national origin, sex, religion, gender, gender identity, political persuasion or sexual orientation.